Brain Scientific Inc. BRSF
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -19.26% | 279.23% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -19.26% | 279.23% | -- | -- | -- |
| Cost of Revenue | -12.16% | 237.78% | -- | -- | -- |
| Gross Profit | -34.74% | 713.39% | -- | -- | -- |
| SG&A Expenses | 11.09% | 167.88% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.10% | 188.93% | -- | -- | -- |
| Operating Income | -11.00% | -164.88% | -- | -- | -- |
| Income Before Tax | -35.64% | -449.05% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -35.64% | -449.05% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -35.64% | -449.05% | -- | -- | -- |
| EBIT | -11.00% | -164.88% | -- | -- | -- |
| EBITDA | -4.11% | -150.76% | -- | -- | -- |
| EPS Basic | 43.95% | -176.54% | -- | -- | -- |
| Normalized Basic EPS | 47.07% | -158.12% | -- | -- | -- |
| EPS Diluted | 43.95% | -175.04% | -- | -- | -- |
| Normalized Diluted EPS | 47.07% | -158.12% | -- | -- | -- |
| Average Basic Shares Outstanding | 161.86% | 83.14% | -- | -- | -- |
| Average Diluted Shares Outstanding | 161.86% | 83.14% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |